aluates Reports

$ 0.0

Automative

Global Colorectal Cancer Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3N14028

Global Colorectal Cancer Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Colorectal Cancer Therapeutics Market Research Report 2025

Code: QYRE-Auto-3N14028

Report

September 2025

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Taiho Pharma

Merck KGaA

Amgen Inc

Takeda

Roche

Eli Lilly

Sanofi

Regeneron

Bayer

Onyx

Bristol-Myers Squib

Sumitomo Dainippon Pharma

Array BioPharma

Hutchison MediPharma

Jiangsu Hengrui Medicine

Jiangsu Chia-Tai Tianqing

Suzhou Zelgen Biopharmaceuticals

Colorectal Cancer Therapeutics Market Size

The global market for Colorectal Cancer Therapeutics was valued at US$ 13350 million in the year 2024 and is projected to reach a revised size of US$ 18620 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Colorectal Cancer Therapeutics Market

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Therapeutics.

The Colorectal Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colorectal Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Colorectal Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Colorectal Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Colorectal Cancer Therapeutics Market
Accounted market size in year	US$ 13350 million
Forecasted market size in 2031	US$ 18620 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Diagnostics Therapeutics
Segment by Application	Hospitals Clinic Research Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Hutchison MediPharma, Jiangsu Hengrui Medicine, Jiangsu Chia-Tai Tianqing, Suzhou Zelgen Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Colorectal Cancer Therapeutics Market growing?

Ans: The Colorectal Cancer Therapeutics Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Colorectal Cancer Therapeutics Market size in 2031?

Ans: The Colorectal Cancer Therapeutics Market size in 2031 will be US$ 18620 million.

Who are the main players in the Colorectal Cancer Therapeutics Market report?

Ans: The main players in the Colorectal Cancer Therapeutics Market are Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Hutchison MediPharma, Jiangsu Hengrui Medicine, Jiangsu Chia-Tai Tianqing, Suzhou Zelgen Biopharmaceuticals

What are the Application segmentation covered in the Colorectal Cancer Therapeutics Market report?

Ans: The Applications covered in the Colorectal Cancer Therapeutics Market report are Hospitals, Clinic, Research Institutions

What are the Type segmentation covered in the Colorectal Cancer Therapeutics Market report?

Ans: The Types covered in the Colorectal Cancer Therapeutics Market report are Diagnostics, Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnostics

1.2.3 Therapeutics

1.3 Market by Application

1.3.1 Global Colorectal Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Research Institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Colorectal Cancer Therapeutics Market Perspective (2020-2031)

2.2 Global Colorectal Cancer Therapeutics Growth Trends by Region

2.2.1 Global Colorectal Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Colorectal Cancer Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Colorectal Cancer Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Colorectal Cancer Therapeutics Market Dynamics

2.3.1 Colorectal Cancer Therapeutics Industry Trends

2.3.2 Colorectal Cancer Therapeutics Market Drivers

2.3.3 Colorectal Cancer Therapeutics Market Challenges

2.3.4 Colorectal Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Colorectal Cancer Therapeutics Players by Revenue

3.1.1 Global Top Colorectal Cancer Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Colorectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Colorectal Cancer Therapeutics Revenue

3.4 Global Colorectal Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Therapeutics Revenue in 2024

3.5 Global Key Players of Colorectal Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Colorectal Cancer Therapeutics, Product and Application

3.7 Global Key Players of Colorectal Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Therapeutics Breakdown Data by Type

4.1 Global Colorectal Cancer Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2026-2031)

5 Colorectal Cancer Therapeutics Breakdown Data by Application

5.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Colorectal Cancer Therapeutics Market Size (2020-2031)

6.2 North America Colorectal Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Colorectal Cancer Therapeutics Market Size by Country (2020-2025)

6.4 North America Colorectal Cancer Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Colorectal Cancer Therapeutics Market Size (2020-2031)

7.2 Europe Colorectal Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Colorectal Cancer Therapeutics Market Size by Country (2020-2025)

7.4 Europe Colorectal Cancer Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Colorectal Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Colorectal Cancer Therapeutics Market Size (2020-2031)

9.2 Latin America Colorectal Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Colorectal Cancer Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Colorectal Cancer Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Colorectal Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Taiho Pharma

11.1.1 Taiho Pharma Company Details

11.1.2 Taiho Pharma Business Overview

11.1.3 Taiho Pharma Colorectal Cancer Therapeutics Introduction

11.1.4 Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.1.5 Taiho Pharma Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Details

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Colorectal Cancer Therapeutics Introduction

11.2.4 Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.2.5 Merck KGaA Recent Development

11.3 Amgen

11.3.1 Amgen Company Details

11.3.2 Amgen Business Overview

11.3.3 Amgen Colorectal Cancer Therapeutics Introduction

11.3.4 Amgen Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.3.5 Amgen Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Colorectal Cancer Therapeutics Introduction

11.4.4 Takeda Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Colorectal Cancer Therapeutics Introduction

11.5.4 Roche Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Colorectal Cancer Therapeutics Introduction

11.6.4 Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Colorectal Cancer Therapeutics Introduction

11.7.4 Sanofi Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Regeneron

11.8.1 Regeneron Company Details

11.8.2 Regeneron Business Overview

11.8.3 Regeneron Colorectal Cancer Therapeutics Introduction

11.8.4 Regeneron Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.8.5 Regeneron Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Colorectal Cancer Therapeutics Introduction

11.9.4 Bayer Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.9.5 Bayer Recent Development

11.10 Onyx

11.10.1 Onyx Company Details

11.10.2 Onyx Business Overview

11.10.3 Onyx Colorectal Cancer Therapeutics Introduction

11.10.4 Onyx Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.10.5 Onyx Recent Development

11.11 Bristol-Myers Squib

11.11.1 Bristol-Myers Squib Company Details

11.11.2 Bristol-Myers Squib Business Overview

11.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Introduction

11.11.4 Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.11.5 Bristol-Myers Squib Recent Development

11.12 Sumitomo Dainippon Pharma

11.12.1 Sumitomo Dainippon Pharma Company Details

11.12.2 Sumitomo Dainippon Pharma Business Overview

11.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Introduction

11.12.4 Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.12.5 Sumitomo Dainippon Pharma Recent Development

11.13 Array BioPharma

11.13.1 Array BioPharma Company Details

11.13.2 Array BioPharma Business Overview

11.13.3 Array BioPharma Colorectal Cancer Therapeutics Introduction

11.13.4 Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.13.5 Array BioPharma Recent Development

11.14 Hutchison MediPharma

11.14.1 Hutchison MediPharma Company Details

11.14.2 Hutchison MediPharma Business Overview

11.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Introduction

11.14.4 Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.14.5 Hutchison MediPharma Recent Development

11.15 Jiangsu Hengrui Medicine

11.15.1 Jiangsu Hengrui Medicine Company Details

11.15.2 Jiangsu Hengrui Medicine Business Overview

11.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Introduction

11.15.4 Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.15.5 Jiangsu Hengrui Medicine Recent Development

11.16 Jiangsu Chia-Tai Tianqing

11.16.1 Jiangsu Chia-Tai Tianqing Company Details

11.16.2 Jiangsu Chia-Tai Tianqing Business Overview

11.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Introduction

11.16.4 Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.16.5 Jiangsu Chia-Tai Tianqing Recent Development

11.17 Suzhou Zelgen Biopharmaceuticals

11.17.1 Suzhou Zelgen Biopharmaceuticals Company Details

11.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview

11.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Introduction

11.17.4 Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2020-2025)

11.17.5 Suzhou Zelgen Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Taiho Pharma

Merck KGaA

Amgen Inc

Takeda

Roche

Eli Lilly

Sanofi

Regeneron

Bayer

Onyx

Bristol-Myers Squib

Sumitomo Dainippon Pharma

Array BioPharma

Hutchison MediPharma

Jiangsu Hengrui Medicine

Jiangsu Chia-Tai Tianqing

Suzhou Zelgen Biopharmaceuticals

List of Tables

Table 1. Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnostics

Table 3. Key Players of Therapeutics

Table 4. Global Colorectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Colorectal Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Colorectal Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Colorectal Cancer Therapeutics Market Share by Region (2020-2025)

Table 8. Global Colorectal Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Colorectal Cancer Therapeutics Market Share by Region (2026-2031)

Table 10. Colorectal Cancer Therapeutics Market Trends

Table 11. Colorectal Cancer Therapeutics Market Drivers

Table 12. Colorectal Cancer Therapeutics Market Challenges

Table 13. Colorectal Cancer Therapeutics Market Restraints

Table 14. Global Colorectal Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Colorectal Cancer Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2024)

Table 17. Ranking of Global Top Colorectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Colorectal Cancer Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Colorectal Cancer Therapeutics, Product and Application

Table 21. Global Key Players of Colorectal Cancer Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Colorectal Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Colorectal Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Colorectal Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Colorectal Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Colorectal Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Colorectal Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Colorectal Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Colorectal Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Colorectal Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Taiho Pharma Company Details

Table 47. Taiho Pharma Business Overview

Table 48. Taiho Pharma Colorectal Cancer Therapeutics Product

Table 49. Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Taiho Pharma Recent Development

Table 51. Merck KGaA Company Details

Table 52. Merck KGaA Business Overview

Table 53. Merck KGaA Colorectal Cancer Therapeutics Product

Table 54. Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Merck KGaA Recent Development

Table 56. Amgen Company Details

Table 57. Amgen Business Overview

Table 58. Amgen Colorectal Cancer Therapeutics Product

Table 59. Amgen Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Amgen Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Colorectal Cancer Therapeutics Product

Table 64. Takeda Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Roche Company Details

Table 67. Roche Business Overview

Table 68. Roche Colorectal Cancer Therapeutics Product

Table 69. Roche Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Eli Lilly Company Details

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Colorectal Cancer Therapeutics Product

Table 74. Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Eli Lilly Recent Development

Table 76. Sanofi Company Details

Table 77. Sanofi Business Overview

Table 78. Sanofi Colorectal Cancer Therapeutics Product

Table 79. Sanofi Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Sanofi Recent Development

Table 81. Regeneron Company Details

Table 82. Regeneron Business Overview

Table 83. Regeneron Colorectal Cancer Therapeutics Product

Table 84. Regeneron Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Regeneron Recent Development

Table 86. Bayer Company Details

Table 87. Bayer Business Overview

Table 88. Bayer Colorectal Cancer Therapeutics Product

Table 89. Bayer Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Bayer Recent Development

Table 91. Onyx Company Details

Table 92. Onyx Business Overview

Table 93. Onyx Colorectal Cancer Therapeutics Product

Table 94. Onyx Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Onyx Recent Development

Table 96. Bristol-Myers Squib Company Details

Table 97. Bristol-Myers Squib Business Overview

Table 98. Bristol-Myers Squib Colorectal Cancer Therapeutics Product

Table 99. Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 100. Bristol-Myers Squib Recent Development

Table 101. Sumitomo Dainippon Pharma Company Details

Table 102. Sumitomo Dainippon Pharma Business Overview

Table 103. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product

Table 104. Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Sumitomo Dainippon Pharma Recent Development

Table 106. Array BioPharma Company Details

Table 107. Array BioPharma Business Overview

Table 108. Array BioPharma Colorectal Cancer Therapeutics Product

Table 109. Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 110. Array BioPharma Recent Development

Table 111. Hutchison MediPharma Company Details

Table 112. Hutchison MediPharma Business Overview

Table 113. Hutchison MediPharma Colorectal Cancer Therapeutics Product

Table 114. Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 115. Hutchison MediPharma Recent Development

Table 116. Jiangsu Hengrui Medicine Company Details

Table 117. Jiangsu Hengrui Medicine Business Overview

Table 118. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product

Table 119. Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 120. Jiangsu Hengrui Medicine Recent Development

Table 121. Jiangsu Chia-Tai Tianqing Company Details

Table 122. Jiangsu Chia-Tai Tianqing Business Overview

Table 123. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product

Table 124. Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 125. Jiangsu Chia-Tai Tianqing Recent Development

Table 126. Suzhou Zelgen Biopharmaceuticals Company Details

Table 127. Suzhou Zelgen Biopharmaceuticals Business Overview

Table 128. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product

Table 129. Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 130. Suzhou Zelgen Biopharmaceuticals Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Colorectal Cancer Therapeutics Picture

Figure 2. Global Colorectal Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Colorectal Cancer Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Diagnostics Features

Figure 5. Therapeutics Features

Figure 6. Global Colorectal Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Colorectal Cancer Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Research Institutions Case Studies

Figure 11. Colorectal Cancer Therapeutics Report Years Considered

Figure 12. Global Colorectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Colorectal Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Colorectal Cancer Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Colorectal Cancer Therapeutics Market Share by Players in 2024

Figure 16. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2024

Figure 18. North America Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Colorectal Cancer Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Colorectal Cancer Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Colorectal Cancer Therapeutics Market Share by Region (2020-2031)

Figure 32. China Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Colorectal Cancer Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Colorectal Cancer Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Colorectal Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 48. Merck KGaA Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 49. Amgen Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 50. Takeda Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 52. Eli Lilly Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 54. Regeneron Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 55. Bayer Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 56. Onyx Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 57. Bristol-Myers Squib Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 58. Sumitomo Dainippon Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 59. Array BioPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 60. Hutchison MediPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 61. Jiangsu Hengrui Medicine Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 62. Jiangsu Chia-Tai Tianqing Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 63. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Colon Cancer Market Research Report 2024

Global Color Detection Sensors Market Research Report 2024

Global Rectal Cancer Therapeutics Market Insights Forecast to 2030

Global Metastatic Colorectal Cancer Surgery Market Research Report 2024

Colorectal Cancer Diagnostics Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Colorectal Cancer Screening Test Market Research Report 2024

Global Colorectal Procedure Market Research Report 2025

Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024

Colorectal Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irinotecan Market Research Report 2024

Metastatic Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Colorectal Cancer Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Colorectal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030

Global Colorectal Surgery Robot Market Research Report 2024

Global Imprime PGG Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions